|
|
||||||||
Departments of Medicine and Physiology and Biophysics, Mayo Clinic and Foundation, Rochester, Minnesota 55905
| |
ABSTRACT |
|---|
|
|
|---|
A significant role for nitric oxide (NO) in proximal tubule physiology and pathophysiology has been revealed by a series of in vivo and in vitro studies. Whether the proximal tubule produces NO under basal conditions is still controversial; however, evidence suggests that the proximal tubule is constantly exposed to NO that might include NO from nonproximal tubule sources. When challenged with a variety of stimuli, including hypoxia, the proximal tubule is able to produce large quantities of NO. In vivo studies generally indicate that NO inhibits fluid and sodium reabsorption by the proximal tubule. However, the final effect of NO on proximal tubular reabsorption appears to depend on the concentration of NO and involve interaction with other regulatory mechanisms. NO regulates Na+-K+-ATPase, Na+/H+ exchangers, and paracellular permeability of proximal tubular cells, which may contribute to its effect on proximal tubular transport. Enhanced production of NO, perhaps depending on macrophage type inducible NO synthase, participates in hypoxic/ischemic proximal tubular injury. In conclusion, NO plays a fundamental role in both physiology and pathophysiology of the proximal tubule.
nitric oxide synthase; kidney; sodium; transport; sodium-potassium adenosine 5'-triphosphatase
| |
INTRODUCTION |
|---|
|
|
|---|
IN THE LAST FEW YEARS, a series of in vivo and in vitro studies have begun to reveal a close relationship between nitric oxide (NO) and the proximal tubule and a significant role of NO in proximal tubule physiology and pathophysiology. The proximal tubule, reabsorbing approximately two-thirds of the Na+ and water filtered by the glomerulus, is quantitatively the most important nephron site for Na+ and water reabsorption. The proximal tubule also plays pivotal roles in the reabsorption of many other substances, including amino acids, glucose, bicarbonate, and phosphate. Abnormalities of proximal tubule function are involved in several important diseases such as acute renal failure.
NO is a small hydrophobic gas molecule. Since being recognized as the molecule accounting for the biological activity of endothelium-derived relaxing factor a little more than a decade ago (25, 54), an amazingly wide variety of biological activities, ranging from vasorelaxation to immune response to neurotransmission, have been shown to involve NO.
Here we reviewed current knowledge and identified gaps in the knowledge regarding production and functional roles of NO in the proximal tubule, with emphasis on the physiology and pathophysiology of proximal tubule function.
| |
PRODUCTION OF NO BY THE PROXIMAL TUBULE |
|---|
|
|
|---|
It is controversial whether the proximal tubule produces NO under basal
conditions. NO is synthesized from L-arginine, catalyzed by
the enzyme NO synthase (NOS). At least three isozymes of NOS have been
identified: endothelial NOS (eNOS), neuronal NOS (nNOS), and inducible
NOS (iNOS). eNOS and nNOS are traditionally called constitutive NOS.
Generally iNOS is only expressed after induction by appropriate
stimuli. However, several tissues, including the proximal tubule,
constitutively express iNOS mRNA. In an in situ hybridization study in
normal rat kidneys using iNOS cRNA, the S3 segment of the proximal
tubule was found to be one of the most intensely labeled nephron
segments (2), whereas the labeling of the S1 and S2 segments of the
proximal convoluted tubule was much weaker. In addition to iNOS, eNOS
mRNA was also detected by RT-PCR in some, but not all, microdissected
rat proximal tubule segments (65). NOS activity measured as the
conversion of L-[3H]arginine to
L-[3H]citrulline and/or
accumulation of NO end-metabolites NO
2 or
NO
2/NO
3
was detected in isolated rat proximal tubules, primary cultures of rat
or human proximal tubule cells, and proximal tubule cell lines (8, 19, 47, 70). In proximal tubules isolated from rat kidneys using Percoll
centrifugation, NOS activity was measured to be ~4-5 nmol L-[3H]citrulline · mg
protein
1 · h
1
(70). In contrast, no studies have shown the presence of NOS proteins
in the proximal tubule under basal conditions, which makes it
questionable whether the proximal tubule is able to produce NO
constitutively. Indeed, using an amperometric NO sensor, Yaqoob et al.
(69) failed to detect NO signals in isolated normoxic rat proximal
tubules. In studies by Terada et al. (61) and Wu et al. (67), mRNAs for
nNOS, eNOS, or iNOS were not detected in microdissected rat proximal
tubules by the RT-PCR technique. It is interesting to note that, unlike
NOS, the mRNA for soluble guanylate cyclase, which mediates many
effects of NO, appears to be more abundant in the proximal tubule than
in most other tubular segments (61). It was reported that the NOS
activity in isolated normoxic rat proximal tubules was inhibited by the NOS inhibitor NG-nitro-L-arginine
methyl ester (L-NAME) (70). However, at concentrations of
up to 10 mM, L-NAME or the relatively selective iNOS
inhibitor aminoguanidine failed to affect the basal accumulation of
NO
2 in the media of opossum kidney
(OK) cells or LLC-PK1 cells, both of which are proximal
tubule cell lines (unpublished data). In any case, one should be
cautious when interpreting the data obtained from isolated proximal
tubules or proximal tubule cell cultures. Proximal tubules in vivo are
exposed to complex neurohormonal microenvironments as well as various
biophysical forces that are mostly lost ex vivo or in vitro. These
factors might affect the ability of proximal tubules to produce NO.
Moreover, isolation procedures and in vitro culturing might alter
certain properties of proximal tubular cells.
Interestingly, a recent microdialysis study showed that there was
detectable NO, measured by hemoglobin trapping, in the microdialysate from the normal rat renal cortex and medulla, which presumably reflects
NO concentrations in renal interstitial fluid (71). NO as well as
NO
2/NO
3
concentrations in the renal microdialysate was decreased by
intravenous infusion of L-NAME and increased by
L-arginine. The presence of NO metabolites in renal
cortical and medullary microdialysate was confirmed in our studies (A. Pfluger and F. G. Knox, unpublished data). These data
indicated that proximal tubules in vivo were constantly exposed to NO
that potentially could affect function of the proximal tubule. The
origin of NO may be from proximal tubules and/or nonproximal tubule
sources, such as the vasculature or other nephron segments. That
vasculature-derived NO may affect proximal tubular functions is
supported by an in vivo study by Amorena and Castro (4), which
suggested that NO released from the endothelium of peritubular capillaries participated in the regulation of proximal tubular acidification. A coincubation study by Linas and Repine (42) also
suggested that endothelial cell-derived NO could regulate the sodium
reabsorption by proximal tubular epithelial cells.
Although it is less certain whether the proximal tubule produces NO
under basal conditions, studies repeatedly showed that the proximal
tubule is able to produce large quantities of NO after appropriate
stimulation. An early study by Markewitz et al. (44), demonstrated that
treatment with tumor necrosis factor (TNF)-
and interferon-
stimulated NO generation from primary cultures of rat proximal tubule
cells, accompanied by substantial increase in iNOS mRNA. The induction
of iNOS and/or NO production in proximal tubule cells by various
combinations of lipopolysaccharide (LPS), interferon-
,
interleukin-1, or TNF-
was confirmed in several studies performed in
primary cultures of mouse (19, 23) and human (47) proximal tubule
cells. In rat kidneys in vivo, treatment with LPS failed to elicit
significant induction of iNOS mRNA in proximal tubules assessed by in
situ hybridization (2). However, a two- to threefold increase of NOS
activity was reported in proximal tubules isolated from LPS-treated
rats (45). Induction of iNOS expression by LPS plus interferon-
in
mouse proximal tubule cells was inhibited by osteopontin,
a secreted Arg-Gly-Asp-containing phosphoprotein (23).
2,4-Diamino-6-hydroxypyrimidine, a tetrahydrobiopterin synthesis
inhibitor, blunted the increase of NO synthesis in mouse proximal
tubule cells induced by LPS plus interferon-
(3). The
13-subunit of G protein, which is coupled to
proinflammatory substances thrombin and thromboxane, also appears to
play a role in the induction of iNOS in the proximal tubule cells
because overexpression of
13 in a mouse proximal convoluted tubule (MCT) cell line, results in increased expression of
the macrophage type of iNOS (29).
In addition to LPS and cytokines, several other factors have also been shown to stimulate NO production in the proximal tubule. One of these factors is hypoxia. With the use of isolated rat proximal tubules, Yu et al. (70) demonstrated that 15-min hypoxia caused significant increase in NOS activity, which was not affected by Ca2+ chelation with EGTA. Hypoxia-induced elevation of NO production from isolated proximal tubules was confirmed by measurements using an amperometric NO sensor (69). This elevation was prevented by extracellular acidosis. No conclusive evidence was provided in these studies as regard to which isoform(s) of NOS was involved. The rather rapid response did not rule out the possible involvement of iNOS, because iNOS mRNA might be constitutively present in proximal tubules and upregulation of iNOS might occur through rapid mechanisms independent of de novo synthesis of the enzyme. On the other hand, lack of effect of Ca2+ chelation with EGTA did not rule out the possible involvement of constitutive NOS, because constitutive forms of NOS independent of free Ca2+ exist (14). In a study by Hwang et al. (24), it was shown that constitutive NOS mRNA in human proximal tubule cells was enhanced during hypoxia. With the use of a video imaging technique, Edelstein et al. (12) observed an early rise in intracellular Ca2+ concentration in rat proximal tubule cells after hypoxic challenge, which is followed by activation of constitutive NOS. These studies suggest that constitutive NOS is involved in hypoxia-stimulated NO production in proximal tubules. However, in a study performed in proximal tubules isolated from mice with knockout of various NOS isoforms, only the knockout of iNOS increased the resistance of the proximal tubule to hypoxic damage (43), which favors the involvement of iNOS rather than eNOS or nNOS in hypoxia-stimulated NO production in proximal tubules.
NO production and NOS activity in rat proximal tubule cells was shown
to increase after treatment with iron for at least 8 h (8). The
approximate twofold increase in
NO
2/NO
3 accumulation after iron treatment was abolished by the relatively selective iNOS inhibitor aminoguanidine. The mechanism of this upregulation is unclear. Atrial natriuretic factor and ANG
II have also been shown to increase NO production in
proximal tubule cells (48).
It is interesting to note that the proximal tubule, particularly the proximal convoluted tubule, is the primary site in the kidney that synthesizes arginine from citrulline (35, 36, 50), suggesting that the substrate of NO synthesis is readily available in this nephron segment. Moreover, the proximal tubule also has locally elevated activity of arginase that degrades arginine to urea and ornithine (37). Therefore, it appears that the proximal tubule plays an important role in renal metabolism of arginine, the substrate for NO synthesis.
| |
ROLE OF NO IN THE REGULATION OF SODIUM AND FLUID TRANSPORT IN THE PROXIMAL TUBULE |
|---|
|
|
|---|
Effects on proximal tubular sodium reabsorption. It has been
shown in several studies performed in humans that systemic
administration of competitive NOS inhibitors decreased fractional
excretion of sodium (FENa) and fractional excretion of
lithium, the latter being an index for sodium transport in the proximal
tubule (5, 7, 49). These results suggest an inhibitory effect of basal NO on proximal tubular sodium reabsorption. In studies performed in
rats, however, it was shown that systemic administration of NOS
inhibitors was natriuretic (20, 27, 28), which appeared to be dependent
on the elevation of renal perfusion pressure and the subsequent
increase in renal interstitial hydrostatic pressure (20). It is
noteworthy that the doses of NOS inhibitors used in the above human and
rat studies were rather different. In the human studies,
NG-monomethyl-L-arginine
(L-NMMA) was given at 3 mg/kg over 10 min (5).
Alternatively, L-NAME was given at 1-25
µg · kg
1 · min
1
for 30 min (7) or at 3 µg · kg
1 · min
1
for 90 min (49). In the studies performed in rats, L-NMMA
was given as a 15 mg/kg bolus followed by continuous infusion at 500 µg · kg
1 · min
1
(20, 27, 28). In a study performed in rats by Lahera et al. (34), it
was shown that L-NAME at the dose of 0.1 or 1 µg · kg
1 · min
1
decreased urinary sodium excretion (UNaV) without affecting
mean arterial pressure (MAP), whereas 10 or 50 µg · kg
1 · min
1
L-NAME increased MAP and reversed the initial fall in
UNaV. In accordance with these data, it seems that the
effect of systemic administration of NOS inhibitors on sodium
reabsorption is affected by other systemic effects of this maneuver.
Therefore, these studies, even with measurements of lithium excretion,
did not provide definitive information regarding direct effects of NO
on the sodium reabsorption in the proximal tubule.
In a microperfusion study in rat kidneys by Wang (66), a biphasic
effect of NO on proximal tubular transport of sodium and bicarbonate
was suggested. An intravenous bolus injection of L-NAME followed by addition of L-NAME to the luminal perfusate
modestly decreased proximal tubular fluid reabsorption
(Jv) and bicarbonate reabsorption
(JHCO
3). When 1 µM sodium nitroprusside (SNP) or
S-nitroso-N-acetylpenicillamine, both of which are NO donors, was added to the luminal perfusion solution,
JV and
JHCO
3 in proximal
convoluted tubules were increased by 30~50%. These increments
appeared to be dependent on cGMP and mediated by stimulation of
Na+/H+ exchangers. When 1 mM SNP was added,
however, proximal tubular JV and
JHCO
3 were
decreased by 50~70%. No data were provided regarding the mechanism
of this inhibition of proximal tubular reabsorption. On the basis of
these data, it was suggested that NO stimulated proximal tubular
reabsorption at lower concentrations and inhibited proximal tubular
reabsorption at higher concentrations. Consistent with an inhibitory
effect of NO on proximal tubular fluid reabsorption, a split-drop
micropuncture study in rat kidneys by Eitle et al. (13), showed that
SNP at the concentration of 0.1 mM added to either the luminal
perfusate or the peritubular perfusate decreased proximal tubular fluid
reabsorption. SNP over the range of 1 µM to 1 mM dose dependently
stimulated cGMP accumulation in proximal tubule suspensions. In
contrast to Wang's studies, no effect on basal proximal tubular fluid
reabsorption was observed with 1 µM SNP.
Altogether, these in vivo studies generally support the notion that NO decreases proximal tubular transport. Compared with systemic drug administration and measurements, microperfusion and micropuncture studies are designed to reduce the systemic interference and better reflect changes in specific tubular segments. However, the diffusibility and metabolic kinetics of NO as well as NOS inhibitors in tubular tissues and renal interstitial fluid are not well delineated. Therefore, it is unclear whether NO or NOS inhibitors administered into the tubular lumen would be confined to the lumen and the surrounding tubular cells. It remains to be determined whether these studies reflect cross-talk of NO with other regulatory mechanisms of proximal tubular transport and/or direct effects of NO on the transport machinery.
Interaction with other mechanisms regulating proximal tubular
sodium reabsorption. Evidence exists that NO can interact with other regulatory mechanisms of proximal tubular transport, including driving forces, ANG II, and renal nerves. Renal interstitial
hydrostatic pressure is an important determinant of the driving force
for tubular transport (18, 30). Systemic administration of NOS inhibitors increases renal perfusion pressure and renal interstitial hydrostatic pressure accompanied by natriuresis (20). When renal interstitial hydrostatic pressure is prevented from increasing by renal
decapsulation, L-NMMA-induced natriuresis is abolished (20). In a study by Nakamura et al. (52), pretreatment of rats with 5 µg · kg
1 · min
1
L-NAME was shown to abolish the increase in renal
interstitial hydrostatic pressure and FELi caused by
increases in renal perfusion pressure, suggesting a role for NO in the
transmission of renal perfusion pressure to renal interstitium.
Interaction with ANG II may also be an important factor in determining the effect of NO on proximal tubular transport, although the mode of interaction remains obscure. ANG II by itself has a dose-dependent biphasic effect on proximal tubular reabsorption (21), being stimulatory at picomolar concentrations and inhibitory at nanomolar concentrations. In a micropuncture study by De Nicola et al. (11), it was shown that L-NMMA markedly decreased the absolute and fractional proximal tubular reabsorption, which was prevented by DUP-753 (losartan), an ANG II type 1 (AT1) receptor antagonist. On the basis of these data, the authors speculated that basal NO masked the inhibitory effect of ANG II and allowed the expression of stimulatory effect of ANG II. However, DuP-753 alone also decreased the absolute and fractional proximal tubular reabsorption (11), suggesting that endogenous ANG II stimulated proximal tubular reabsorption through AT1 receptors. Therefore, it is not clear why the absolute and fractional proximal tubular reabsorption remained unchanged in the presence of both L-NMMA and DUP-753. In contrast, in the split-drop micropuncture study by Eitle et al. (13), SNP (1 µM or 0.1 mM) abolished the stimulatory effect of luminal ANG II (1 nM) on proximal tubular fluid reabsorption.
Regulation of proximal tubular reabsorption involves renal adrenergic
nerve activity (30). A study by Gabbai et al. (15) showed that
intravenous infusion of L-NMMA (30 mg · kg
1 · h
1)
decreased fractional proximal reabsorption in Munich-Wistar rats. When
kidneys were denervated ~1 wk before the experiment, the decrease in
fractional proximal reabsorption by L-NMMA was prevented
(15). However, closer inspection of the data reveals that
L-NMMA similarly decreased the fractional proximal
reabsorption from 43 to 35% in sham-operated rats and from 43 to 36%
in denervated rats, although the difference was statistically
significant in sham-operated rats, but not in denervated rats. In a
study by Thomson and Vallon (62) using similar experimental design,
denervation was again shown to abolish the decrease in fractional
proximal reabsorption caused by L-NMMA. The effect of
denervation was reversed by systemic infusion of the
2-agonist B-HT-933. Moreover, in innervated rats,
infusion of the
2-antagonist yohimbine abolished the
inhibitory effect of L-NMMA on the fractional proximal
reabsorption. With the use of acute renal denervation, however, Khraibi
(28) showed that, in Wistar-Kyoto rats, the natriuretic effect of
L-NMMA was not dependent on renal innervation, whereas it
was attenuated by acute renal denervation in Okamoto spontaneously
hypertensive rats.
Effects on the machinery for proximal tubular sodium reabsorption.
With regard to direct effects of NO on the proximal tubular transport machinery, several studies have been performed in in vitro
proximal tubules or proximal tubule cell cultures to identify the
targets of NO and the mechanism. Proximal tubular transport is
primarily driven by Na+-K+-ATPase located on
the basolateral membrane. A study by McKee et al. (46) demonstrated
that endogenous or exogenous NO inhibited Na+-K+-ATPase activity in rat renal medulla
slices. This study did not examine which tubular segments were the
source of Na+-K+-ATPase and NO involved in the
observed inhibition. In a study performed in MCT cells, a mouse
proximal tubular cell line, Guzman et al. (19) showed that both
LPS-interferon-
-stimulated endogenous NO and NO donors SNP (0.4 mM)
or SIN-1 (30 µM) inhibited Na+-K+-ATPase by
~30%. This effect of NO was prevented by superoxide dismutase and
partially mimicked by a cGMP analog but not affected by alteration of
Na+ entry into the cell. On the basis of these data, it was
suggested that peroxynitrite played a role in this inhibition. The
inhibitory effect of NO on proximal tubular
Na+-K+-ATPase was confirmed by studies
performed in OK cells, another proximal tubular cell line (40). This
inhibition reflects a reduction of
Na+-K+-ATPase molecular activity rather than
changes in number of functional enzyme units on cell surface as
measured by ouabain binding. This is in contrast with effect of NO on
the Na+-K+-ATPase in a medullary thick
ascending limb cell line that appeared to involve inhibition of
transcription of
1-subunit of this enzyme (32). The
inhibition of Na+-K+-ATPase in OK cells by NO
was reproduced by a cGMP analog and blunted by a soluble guanylate
cyclase inhibitor, suggesting a role for cGMP in mediating this
inhibition. Furthermore, NO was shown to activate protein kinase C-
(PKC-
) in OK cells and the inhibition of
Na+-K+-ATPase by NO in OK cells was abolished
by PKC inhibitors, but not by a cGMP-dependent protein kinase inhibitor
(38). These data indicate that the inhibition of
Na+-K+-ATPase by NO in proximal tubular OK
cells involves activation of PKC-
, a mechanism shared by several
other hormones such as dopamine (10). It remains to be determined how
NO activates PKC-
in OK cells and how cGMP and PKC-
interact with
each other in mediating the inhibition of
Na+-K+-ATPase by NO. Interestingly, NO did not
affect the Na+-K+-ATPase activity in
LLC-PK1 cells, a proximal tubular cell line of pig origin,
suggesting the presence of heterogeneity of regulation of proximal
tubular Na+-K+-ATPase by NO (38). In addition
to Na+-K+-ATPase,
Na+/H+ exchangers that mediate the majority of
Na+ entry through the apical membrane of proximal tubular
epithelia have also been shown to be affected by NO. In cultured rabbit proximal tubular cells, NO donors inhibited
Na+/H+ exchanger activity by ~30%, which was
reproduced by a cGMP analog and partially prevented by a soluble
guanylate cyclase inhibitor (56).
Effects of NO on Na+-K+-ATPase and Na+/H+ exchangers demonstrated in these studies are consistent with an inhibitory role of NO in the regulation of proximal tubular reabsorption. It is important to note that doses of the NO donor SNP used in these studies were in the range of 0.4-1 mM (19, 40, 56), which are close to doses shown to inhibit proximal tubular reabsorption in vivo (13, 66) but substantially higher than the dose shown to stimulate proximal tubular reabsorption in vivo (66). Although several in vivo microperfusion and micropuncture studies suggest a stimulatory role of basal NO on proximal reabsorption (11, 66), no study has demonstrated stimulatory effects of NO on the machinery for proximal sodium reabsorption.
Effects on proximal tubular paracellular transport. In addition to a transcellular pathway, proximal tubules possess an unusually leaky paracellular pathway (17). Although the exact quantity is not yet clear, taking the literature as a whole, about one-third of the total fluid reabsorption in the proximal tubule occurs through the paracellular pathway (17). In a study using OK cell sheets cultured on permeable supports, whose paracellular permeability is close to that of the in vivo proximal tubule (41), NO was shown to increase the paracellular permeability of OK cells (39). This effect of NO appeared to involve reduction of cellular ATP content. The dose of the NO donor SNP required to elicit this effect, although conceivably available in proximal tubules, was rather high (2 mM for 24 h), suggesting that this effect of NO might be relevant under circumstances with prolonged overproduction of NO. As described in PRODUCTION OF NO BY THE PROXIMAL TUBULE, NO production in proximal tubules could be substantially and rapidly enhanced under situations such as hypoxia/reoxygenation (70). The overproduction of NO in kidneys persists at 24 h after ischemia-reperfusion injury (9, 53). In a study by Kwon et al. (33), it was shown that the paracellular permeability of proximal tubules was enhanced in human postischemic renal allografts with sustained acute renal failure. It would be interesting to determine if overproduction of NO plays a role in this pathological change.
An integrative view of the role of proximal tubular effects of NO
in the regulation of fluid and electrolyte homeostasis. Reported
effects of NO on the proximal tubular transport are summarized in Fig.
1. Despite the apparent controversy
engendered by the natriuretic effects of L-NMMA, the effect
of NO on the proximal tubular transport machinery in vitro (19, 38, 40,
56) and the effect of NO donors (0.1-1 mM SNP) on the proximal
tubular fluid reabsorption in vivo (13, 66) indicate that NO functions as an inhibitor for the proximal tubular fluid and sodium reabsorption. This is in concert with inhibitory effects of NO on fluid and sodium
reabsorption in other tubular segments (16, 32, 59). In this sense, NO
is a natriuretic agent. This is, in principle, consistent with the
prominent role of NO in maintaining vascular tone and preventing
increase in blood pressure. However, the final effect of NO on proximal
tubular sodium reabsorption and its role in the overall fluid and
electrolyte homeostasis may vary under different circumstances. This is
mainly caused by the complex effect of NO on various targets, including
hemodynamics, the renin-angiotensin system, and the tubular system. For
example, increases in arterial blood pressure and renal interstitial
hydrostatic pressure caused by systemic inhibition of NO synthesis lead
to decreases in tubular reabsorption of fluid and sodium (20, 52). In
this case, inhibition of NO synthesis is natriuretic. Apparently, the
natriuresis seen under this situation would favor the return of the
abnormally increased arterial blood pressure to normal. Therefore, the
role of NO in the regulation of proximal tubular transport can only be
understood when it is integrated with other aspects of NO functions and
when it is properly incorporated into the overall regulation of fluid
and electrolyte homeostasis.
|
| |
ROLE OF NO IN THE INJURY OF PROXIMAL TUBULES |
|---|
|
|
|---|
NO belongs to a class of relatively weak free radicals. It can react with a variety of substances, including oxygen, superoxide anion, thiol groups, heme proteins, peroxyl radicals, iron-sulfur complexes, and nonthiol amino acid residues (22). Some products of these reactions, such as peroxynitrite and hydroxyl radical, are cytotoxic. Some of these reactions also have deleterious effects. Consistently, NO has been shown to be involved in the pathophysiology of many diseases, including kidney diseases (31). On the other hand, other functions of NO, such as maintaining vascular tone and antiplatelet aggregation, may have beneficial effects under certain circumstances.
Several studies related to the toxic effect of NO on proximal tubules
were performed in the context of acute renal failure. As mentioned
above, either through iNOS or constitutive NOS, NO production by
proximal tubules is enhanced by hypoxia. Increases in lactate
dehydrogenase (LDH) release from isolated rat proximal tubules caused by 15 min of hypoxia followed by 35 min of reoxygenation were prevented by L-NAME and enhanced by
L-arginine, the substrate for NO synthesis (70). Addition
of SNP further enhanced hypoxia/reoxygenation injury, which was
prevented by the NO scavenger hemoglobin. These data indicated a
pivotal role of NO in the hypoxic injury of proximal tubules. In
contrast to a deleterious role of NO, inhibition of NOS in vivo with
NOS inhibitors was shown to aggravate renal dysfunction in renal
ischemia or radiocontrast or cyclosporin nephrotoxicity (1, 6,
53, 58), suggesting a beneficial role of NO in these models of acute
renal failure. One explanation for this discrepancy was the
nonspecificity of NOS inhibitors that might compromise the potential
protective effect of eNOS-derived NO. With the use of isoform-specific
oligodeoxynucleotides, Noiri et al. (53) showed that in vivo targeting
of iNOS protected rat kidney against ischemia. Both the
elevation of NO production and iNOS induction in rat kidneys caused by
ischemia were largely blunted by targeting of iNOS with
oligodeoxynucleotides. In the meantime, normal renal function and renal
tubular histology were preserved. It is interesting to note that
oligodeoxynucleotides targeted specifically to vascular smooth muscle
type of iNOS did not protect kidneys against ischemia, but
rather exacerbated renal ischemic injury. This suggests that
perhaps only macrophage-type iNOS-derived NO is involved in renal
ischemic injury. In agreement with Noiri's studies, Chiao et al.
(9) also demonstrated that iNOS proteins in outer medulla were
increased after bilateral renal ischemia and that
-melanocyte-stimulating hormone, a potent anti-inflammatory agent,
protected against renal ischemic injury concomitant with inhibition
of iNOS induction. These studies indicated that iNOS-derived NO was
responsible for NO-mediated renal toxicity in acute renal failure. This
is in agreement with an in vitro study showing that proximal tubules
isolated from mice lacking iNOS, but not eNOS or nNOS, were resistant
to hypoxic injury (43). On the other hand, several studies suggested
that constitutive forms of NOS in proximal tubular cells were activated
by hypoxia (12, 24). The role of this activation of constitutive NOS is
not clear. In the study by Noiri et al. (53), increment of eNOS
proteins in kidney tissues was minimal after ischemia.
NO has also been shown to participate in the cytotoxic effect of lipid
A (63, 64), HgCl2 (68), and iron (8) on proximal tubule
cells. Treatment with iron increased
NO
2/NO
3 accumulation in the media of rat proximal tubular cells by about twofold. However, the relatively selective iNOS inhibitor
aminoguanidine, which completely abolished iron-induced NO production,
only partially blunted iron-induced LDH release (8). This suggests that
NO only plays a partial role in the iron toxicity in proximal tubules.
As mentioned in an earlier section, the proximal tubule is also rich in arginase activity that degrades arginine to form urea and ornithine (37). Ornithine is the precursor for the synthesis of polyamines that are required for cell proliferation and L-proline that is a substrate for collagen synthesis (26, 51). NO, on the other hand, is known to cause cytostasis (55, 60). In a study performed in a mouse proximal tubule cell line, exogenous NO or cytokine-induced endogenous NO production was shown to inhibit both the rate-limiting enzyme for polyamine synthesis and the uptake of polyamines (57). The interaction between the two pathways of arginine metabolism may be of significance in the regulation of cell proliferation.
| |
PERSPECTIVES |
|---|
|
|
|---|
Although substantial progress in the understanding of the production and effects of NO by and on the proximal tubule has been made, it is evident that many inconsistencies and gaps remain. Studies aimed to dissect the effect of NO on the proximal tubule at cellular and molecular levels should be helpful in further defining the role of NO in this tubular segment and its mechanisms. Equally important is the integration of the direct effect of NO on the proximal tubule and the wide variety of other effects of NO. Both lines of studies are critical in enhancing our understanding of NO biology and proximal tubule physiology as well as in developing effective interventions in case of abnormal proximal tubular transport or proximal tubular injury. For example, it would be very interesting to determine whether NO production in the proximal tubule is altered by sodium loading or volume expansion and whether the regulation of proximal tubular transport by NO plays any role in the response to sodium loading or volume expansion. Novel approaches need to be developed to address these questions. For instance, approaches allowing in vivo measurement of proximal tubule-specific NO production and those allowing proximal tubule selective manipulation of NO production, such as proximal tubule-targeted disruption or delivery of NOS, would be helpful.
| |
SUMMARY |
|---|
|
|
|---|
Although whether the proximal tubule produces NO under basal conditions is still controversial, evidence suggests that the proximal tubule is constantly exposed to NO. Moreover, the proximal tubule is able to produce large quantities of NO upon a variety of stimulation. NO plays an important role in regulating proximal tubular reabsorption of fluid, sodium, bicarbonate, and phosphate. NO regulates Na+-K+-ATPase, Na+/H+ exchangers, and paracellular permeability of proximal tubular cells, which may contribute to its effect on proximal tubular transport. The final effect of NO on proximal tubular reabsorption appears to depend on the concentration of NO and involve interaction with other regulatory mechanisms. Enhanced production of NO, perhaps macrophage-type inducible NO synthase-dependent production of NO, participates in hypoxic/ischemic proximal tubular injury. In conclusion, NO plays an indispensable and fundamental role in both physiology and pathophysiology of the proximal tubule.
| |
ACKNOWLEDGEMENTS |
|---|
The authors gratefully acknowledge Joanne Zimmerman for the expert secretarial assistance and the laboratory group and Dr. Karl A. Nath for critical reading of this manuscript.
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: F. G. Knox, Dept. of Physiology and Biophysics, Mayo Clinic and Foundation, Rochester, MN 55905 (E-mail: knox.franklyn{at}mayo.edu).
| |
REFERENCES |
|---|
|
|
|---|
1.
Agmon, Y,
Peleg H,
Greenfeld Z,
Rosen S,
and
Brezis M.
Nitric oxide and prostanoids protect the renal outer medulla from radiocontrast toxicity in the rat.
J Clin Invest
94:
1069-1075,
1994.
2.
Ahn, KY,
Mohaupt MG,
Madsen KM,
and
Kone BC.
In situ hybridization localization of mRNA encoding inducible nitric oxide synthase in rat kidney.
Am J Physiol Renal Fluid Electrolyte Physiol
267:
F748-F757,
1994
3.
Amoah-Apraku, B,
Tang SS,
Ingelfinger JR,
and
Guzman NJ.
Guanosine triphosphate cyclohydrolase I regulates nitric oxide synthesis in renal proximal tubules.
J Am Soc Nephrol
5:
1630-1633,
1995[Abstract].
4.
Amorena, C,
and
Castro AF.
Control of proximal tubule acidification by the endothelium of the peritubular capillaries.
Am J Physiol Regulatory Integrative Comp Physiol
272:
R691-R694,
1997
5.
Bech, JN,
Nielsen CB,
and
Pedersen EB.
Effects of systemic NO synthesis inhibition on RPF, GFR, UNa, and vasoactive hormones in healthy humans.
Am J Physiol Renal Fluid Electrolyte Physiol
270:
F845-F851,
1996
6.
Bobadilla, NA,
Tapia E,
Franco M,
Lopez P,
Mendoza S,
Garcia-Torres R,
Alvarado JA,
and
Herrera-Acosta J.
Role of nitric oxide in renal hemodynamic abnormalities of cyclosporin nephrotoxicity.
Kidney Int
46:
773-779,
1994[Web of Science][Medline].
7.
Broere, A,
Van Den Meiracker AH,
Boomsma F,
Derkx FH,
Veld AJ,
and
Schalekamp MA.
Human renal and systemic hemodynamic, natriuretic, and neurohumoral responses to different doses of L-NAME.
Am J Physiol Renal Physiol
275:
F870-F877,
1998
8.
Chen, L,
Zhang BH,
and
Harris DC.
Evidence suggesting that nitric oxide mediates iron-induced toxicity in cultured proximal tubule cells.
Am J Physiol Renal Physiol
274:
F18-F25,
1998
9.
Chiao, H,
Kohda Y,
McLeroy P,
Craig L,
Housini I,
and
Star RA.
-Melanocyte-stimulating hormone protects against renal injury after ischemia in mice and rats.
J Clin Invest
99:
1165-1172,
1997[Web of Science][Medline].
10.
Chibalin, AV,
Pedemonte CH,
Katz AI,
Feraille E,
Berggren PO,
and
Bertorello AM.
Phosphorylation of the catalytic alpha-subunit constitutes a triggering signal for Na+,K+-ATPase endocytosis.
J Biol Chem
273:
8814-8819,
1998
11.
De Nicola, L,
Blantz RC,
and
Gabbai FB.
Nitric oxide and angiotensin II. Glomerular and tubular interaction in the rat.
J Clin Invest
89:
1248-1256,
1992.
12.
Edelstein, CL,
Yaqoob MM,
and
Schrier RW.
The role of the calcium-dependent enzymes nitric oxide synthase and calpain in hypoxia-induced proximal tubule injury.
Ren Fail
18:
501-511,
1996[Web of Science][Medline].
13.
Eitle, E,
Hiranyachattada S,
Wang H,
and
Harris PJ.
Inhibition of proximal tubular fluid absorption by nitric oxide and atrial natriuretic peptide in rat kidney.
Am J Physiol Cell Physiol
274:
C1075-C1080,
1998
14.
Fleming, I,
Bauersachs J,
and
Russe R.
Calcium-dependent and calcium-independent activation of the endothelial NO synthase.
J Vasc Res
34:
165-174,
1997[Web of Science][Medline].
15.
Gabbai, FB,
Thomson SC,
Peterson O,
Wead L,
Malvey K,
and
Blantz RC.
Glomerular and tubular interactions between renal adrenergic activity and nitric oxide.
Am J Physiol Renal Fluid Electrolyte Physiol
268:
F1004-F1008,
1995
16.
Garcia, NH,
Pomposiello SI,
and
Garvin JL.
Nitric oxide inhibits ADH-stimulated osmotic water permeability in cortical collecting ducts.
Am J Physiol Renal Fluid Electrolyte Physiol
270:
F206-F210,
1996
17.
Garcia, NH,
Ramsey CR,
and
Knox FG.
Understanding the role of paracellular pathway transport in the proximal tubule.
News Physiol Sci
13:
38-43,
1998
18.
Granger, JP.
Regulation of sodium excretion by renal interstitial hydrostatic pressure.
Fed Proc
45:
2892-2896,
1986[Web of Science][Medline].
19.
Guzman, NJ,
Fang MZ,
Tang SS,
Ingelfinger JR,
and
Garg LC.
Autocrine inhibition of Na+/K(+)-ATPase by nitric oxide in mouse proximal tubule epithelial cells.
J Clin Invest
95:
2083-2088,
1995.
20.
Haas, JA,
Khraibi AA,
Perrella MA,
and
Knox FG.
Role of renal interstitial hydrostatic pressure in natriuresis of systemic nitric oxide inhibition.
Am J Physiol Renal Fluid Electrolyte Physiol
264:
F411-F414,
1993
21.
Harris, PJ,
and
Navar LG.
Tubular transport responses to angiotensin.
Am J Physiol Renal Fluid Electrolyte Physiol
248:
F621-F623,
1985
22.
Hogg, N,
and
Griffith OW.
The biological chemistry of NO.
In: Nitric Oxide and the Kidney: Physiology and Pathophysiology, edited by Goligorsky MS,
and Gross SS.. New York: Chapman & Hall, 1997.
23.
Hwang, SM,
Lopez CA,
Heck DE,
Gardner CR,
Laskin DL,
Laskin JD,
and
Denhardt DT.
Osteopontin inhibits induction of nitric oxide synthase gene expression by inflammatory mediators in mouse kidney epithelial cells.
J Biol Chem
269:
711-715,
1994
24.
Hwang, SM,
Wilson PD,
Laskin JD,
and
Denhardt DT.
Age and development-related changes in osteopontin and nitric oxide synthase mRNA levels in human kidney proximal tubule epithelial cells: contrasting responses to hypoxia and reoxygenation.
J Cell Physiol
160:
61-68,
1994[Web of Science][Medline].
25.
Ignarro, LJ,
Buga GM,
Wood KS,
Byrns RE,
and
Chaudhuri G.
Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.
Proc Natl Acad Sci USA
84:
9265-9269,
1987
26.
Ketteler, M,
Border WA,
and
Noble NA.
Cytokines and L-arginine in renal injury and repair.
Am J Physiol Renal Fluid Electrolyte Physiol
267:
F197-F207,
1994
27.
Khraibi, AA.
Inhibition of nitric oxide causes exaggerated natriuresis in spontaneously hypertensive rats.
Am J Physiol Renal Fluid Electrolyte Physiol
266:
F762-F766,
1994
28.
Khraibi, AA.
Role of renal nerves in natriuresis of L-NMMA infusion in SHR and WKY rats.
Am J Physiol Renal Fluid Electrolyte Physiol
269:
F17-F21,
1995
29.
Kitamura, K,
Singer WD,
Star RA,
Muallem S,
and
Miller RT.
Induction of inducible nitric-oxide synthase by the heterotrimeric G protein Galpha13.
J Biol Chem
271:
7412-7415,
1996
30.
Knox, FG,
and
Granger JP.
Control of sodium excretion: an integrative approach.
In: Handbook of Physiology. Renal Physiology. Bethesda, MD: Am. Physiol. Soc, 1992, sect. 8, vol. I, chapt. 21, p. 927-967.
31.
Kone, BC.
Nitric oxide in renal health and disease.
Am J Kidney Dis
30:
311-333,
1997[Web of Science][Medline].
32.
Kone, BC,
and
Higham S.
Nitric oxide inhibits transcription of the Na+-K+-ATPase
1-subunit gene in an MTAL cell line.
Am J Physiol Renal Physiol
277:
F614-F621,
1999.
33.
Kwon, O,
Nelson WJ,
Sibley R,
Huie P,
Scandling JD,
Dafoe D,
Alfrey E,
and
Myers BD.
Backleak, tight junctions, and cell-cell adhesion in postischemic injury to the renal allograft.
J Clin Invest
101:
2054-2064,
1998[Web of Science][Medline].
34.
Lahera, V,
Salom MG,
Miranda-Guardiola F,
Moncada S,
and
Romero JC.
Effects of NG-nitro-L-arginine methyl ester on renal function and blood pressure.
Am J Physiol Renal Fluid Electrolyte Physiol
261:
F1033-F1037,
1991
35.
Levillain, O,
Hus-Citharel A,
Morel F,
and
Bankir L.
Arginine synthesis in mouse and rabbit nephron: localization and functional significance.
Am J Physiol Renal Fluid Electrolyte Physiol
264:
F1038-F1045,
1993
36.
Levillain, O,
Hus-Citharel A,
Morel F,
and
Bankir L.
Localization of arginine synthesis along rat nephron.
Am J Physiol Renal Fluid Electrolyte Physiol
259:
F916-F923,
1990
37.
Levillain, O,
Hus-Citharel A,
Morel F,
and
Bankir L.
Localization of urea and ornithine production along mouse and rabbit nephrons: functional significance.
Am J Physiol Renal Fluid Electrolyte Physiol
263:
F878-F885,
1992
38.
Liang, M,
and
Knox FG.
Nitric oxide activates PKC
and inhibits Na+-K+-ATPase in opossum kidney cells.
Am J Physiol Renal Physiol
277:
F859-F865,
1999
39.
Liang, M,
and
Knox FG.
Nitric oxide enhances paracellular permeability of opossum kidney cells.
Kidney Int
55:
2215-2223,
1999[Web of Science][Medline].
40.
Liang, M,
and
Knox FG.
Nitric oxide reduces the molecular activity of Na+-K+-ATPase in opossum kidney cells.
Kidney Int
56:
627-634,
1999[Web of Science][Medline].
41.
Liang, M,
Ramsey CR,
and
Knox FG.
Paracellular permeability of opossum kidney cells, a proximal tubular cell line.
Kidney Int
56:
2304-2308,
1999[Web of Science][Medline].
42.
Linas, SL,
and
Repine JE.
Endothelial cells regulate proximal tubule epithelial cell sodium transport.
Kidney Int
55:
1251-1258,
1999[Web of Science][Medline].
43.
Ling, H,
Gengaro PE,
Edelstein CL,
Martin PY,
Wangsiripaisan A,
Nemenoff R,
and
Schrier RW.
Effect of hypoxia on proximal tubules isolated from nitric oxide synthase knockout mice.
Kidney Int
53:
1642-1646,
1998[Web of Science][Medline].
44.
Markewitz, BA,
Michael JR,
and
Kohan DE.
Cytokine-induced expression of a nitric oxide synthase in rat renal tubule cells.
J Clin Invest
91:
2138-2143,
1993.
45.
Mayeux, PR,
Garner HR,
Gibson JD,
and
Beanum VC.
Effect of lipopolysaccharide on nitric oxide synthase activity in rat proximal tubules.
Biochem Pharmacol
49:
115-118,
1995[Web of Science][Medline].
46.
McKee, M,
Scavone C,
and
Nathanson JA.
Nitric oxide, cGMP, and hormone regulation of active sodium transport.
Proc Natl Acad Sci USA
91:
12056-12060,
1994
47.
McLay, JS,
Chatterjee P,
Nicolson AG,
Jardine AG,
McKay NG,
Ralston SH,
Grabowski P,
Haites NE,
MacLeod AM,
and
Hawksworth GM.
Nitric oxide production by human proximal tubular cells: a novel immunomodulatory mechanism?
Kidney Int
46:
1043-1049,
1994[Web of Science][Medline].
48.
McLay, JS,
Chatterjee PK,
Mistry SK,
Weerakody RP,
Jardine AG,
McKay NG,
and
Hawksworth GM.
Atrial natriuretic factor and angiotensin II stimulate nitric oxide release from human proximal tubular cells.
Clin Sci (Colch)
89:
527-531,
1995[Medline].
49.
Montanari, A,
Tateo E,
Fasoli E,
Donatini A,
Cimolato B,
Perinotto P,
and
Dall'Aglio P.
Dopamine-2 receptor blockade potentiates the renal effects of nitric oxide inhibition in humans.
Hypertension
31:
277-282,
1998
50.
Morel, F,
Hus-Citharel A,
and
Levillain O.
Biochemical heterogeneity of arginine metabolism along kidney proximal tubules.
Kidney Int
49:
1608-1610,
1996[Web of Science][Medline].
51.
Morgan, DM.
Polyamines, arginine and nitric oxide.
Biochem Soc Trans
22:
879-883,
1994[Web of Science][Medline].
52.
Nakamura, T,
Alberola AM,
Salazar FJ,
Saito Y,
Kurashina T,
Granger JP,
and
Nagai R.
Effects of renal perfusion pressure on renal interstitial hydrostatic pressure and Na+ excretion: role of endothelium-derived nitric oxide.
Nephron
78:
104-111,
1998[Web of Science][Medline].
53.
Noiri, E,
Peresleni T,
Miller F,
and
Goligorski MS.
In vivo targeting of inducible NO synthase with oligodeoxynucleotides protects rat kidneys against ischemia.
J Clin Invest
97:
2377-2383,
1996[Web of Science][Medline].
54.
Palmer, RMJ,
Ferrige AG,
and
Moncada S.
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.
Nature
327:
524-526,
1987[Medline].
55.
Peunova, N,
and
Enikolopov G.
Nitric oxide triggers a switch to growth arrest during differentiation of neuronal cells.
Nature
375:
68-73,
1995[Medline].
56.
Roczniak, A,
and
Burns KD.
Nitric oxide stimulates guanylate cyclase and regulates sodium transport in rabbit proximal tubule.
Am J Physiol Renal Fluid Electrolyte Physiol
270:
F106-F115,
1996
57.
Satriano, J,
Ishizuka S,
Archer DC,
Blantz RC,
and
Kelly CJ.
Regulation of intracellular polyamine biosynthesis and transport by NO and cytokines TNF-
and IFN-
.
Am J Physiol Cell Physiol
276:
C892-C899,
1999
58.
Schwartz, D,
Blum M,
Peer G,
Wollman Y,
Maree A,
Serban I,
Grosskopf S,
Cabili S,
Levo Y,
and
Iaina A.
Role of nitric oxide (EDRF) in radiocontrast acute renal failure in rats.
Am J Physiol Renal Fluid Electrolyte Physiol
267:
F374-F379,
1994
59.
Stoos, BA,
Garcia NH,
and
Garvin JL.
Nitric oxide inhibits sodium reabsorption in the isolated perfused cortical collecting duct.
J Am Soc Nephrol
6:
89-94,
1995[Abstract].
60.
Stuehr, DJ,
and
Nathan CF.
Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells.
J Exp Med
169:
1543-1555,
1989
61.
Terada, Y,
Tomita K,
Nonoguchi H,
and
Marumo F.
Polymerase chain reaction localization of constitutive nitric oxide synthase and soluble guanylate cyclase messenger RNAs in microdissected rat nephron segments.
J Clin Invest
90:
659-665,
1992.
62.
Thomson, SC,
and
Vallon V.
Alpha 2-adrenoceptors determine the response to nitric oxide inhibition in the rat glomerulus and proximal tubule.
J Am Soc Nephrol
6:
1482-1490,
1995[Abstract].
63.
Traylor, LA,
and
Mayeux PR.
Nitric oxide generation mediates lipid A-induced oxidant injury in renal proximal tubules.
Arch Biochem Biophys
338:
129-135,
1997[Web of Science][Medline].
64.
Traylor, LA,
Proksch JW,
Beanum VC,
and
Mayeux PR.
Nitric oxide generation by renal proximal tubules: role of nitric oxide in the cytotoxicity of lipid A.
J Pharmacol Exp Ther
279:
91-96,
1996
65.
Ujiie, K,
Yuen J,
Hogarth L,
Danziger R,
and
Star RA.
Localization and regulation of endothelial NO synthase mRNA expression in rat kidney.
Am J Physiol Renal Fluid Electrolyte Physiol
267:
F296-F302,
1994
66.
Wang, T.
Nitric oxide regulates HCO
3 and Na+ transport by a cGMP-mediated mechanism in the kidney proximal tubule.
Am J Physiol Renal Physiol
272:
F242-F248,
1997
67.
Wu, F,
Park F,
Cowley AW,
and
Mattson DL.
Quantification of nitric oxide synthase activity in microdissected segments of the rat kidney.
Am J Physiol Renal Physiol
276:
F874-F881,
1999
68.
Yanagisawa, H,
Nodera M,
Umemori Y,
Shimoguchi Y,
and
Wada O.
Role of angiotensin II, endothelin-1, and nitric oxide in HgCl2-induced acute renal failure.
Toxicol Appl Pharmacol
152:
315-326,
1998[Web of Science][Medline].
69.
Yaqoob, M,
Edelstein CL,
Wieder ED,
Alkhunaizi AM,
Gengaro PE,
Nemenoff RA,
and
Schrier RW.
Nitric oxide kinetics during hypoxia in proximal tubules: effects of acidosis and glycine.
Kidney Int
49:
1314-1319,
1996[Web of Science][Medline].
70.
Yu, L,
Gengaro PE,
Niederberger M,
Burke TJ,
and
Schrier RW.
Nitric oxide: a mediator in rat tubular hypoxia/reoxygenation injury.
Proc Natl Acad Sci USA
91:
1691-1695,
1994
71.
Zou, A-P,
and
Cowley AW, Jr.
Nitric oxide in renal cortex and medulla: an in vivo microdialysis study.
Hypertension
29:
194-198,
1997
This article has been cited by other articles:
![]() |
A. A. Banday and M. F. Lokhandwala Inhibition of natriuretic factors increases blood pressure in rats Am J Physiol Renal Physiol, August 1, 2009; 297(2): F397 - F402. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Liu, D. Mladinov, J. L. Pietrusz, K. Usa, and M. Liang Glucocorticoid response elements and 11{beta}-hydroxysteroid dehydrogenases in the regulation of endothelial nitric oxide synthase expression Cardiovasc Res, January 1, 2009; 81(1): 140 - 147. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Salom, S. Nieto Ceron, F. Rodriguez, B. Lopez, I. Hernandez, J. Gil Martinez, A. Martinez Losa, and F. J. Fenoy Heme oxygenase-1 induction improves ischemic renal failure: role of nitric oxide and peroxynitrite Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3542 - H3549. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Ahmed, B. A. Kemp, N. L. Howell, H. M. Siragy, and R. M. Carey Extracellular Renal Guanosine Cyclic 3'5'-Monophosphate Modulates Nitric Oxide and Pressure-Induced Natriuresis Hypertension, November 1, 2007; 50(5): 958 - 963. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Miloradovic, M. Jerkic, D. Jovovic, N. Mihailovic-Stanojevic, J. G. Milanovic, G. Stosic, and J. Markovic-Lipkovski Bosentan and losartan ameliorate acute renal failure associated with mild but not strong NO blockade Nephrol. Dial. Transplant., September 1, 2007; 22(9): 2476 - 2484. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Tripatara, N. S.A. Patel, A. Webb, K. Rathod, F. M.J. Lecomte, E. Mazzon, S. Cuzzocrea, M. M. Yaqoob, A. Ahluwalia, and C. Thiemermann Nitrite-Derived Nitric Oxide Protects the Rat Kidney against Ischemia/Reperfusion Injury In Vivo: Role for Xanthine Oxidoreductase J. Am. Soc. Nephrol., February 1, 2007; 18(2): 570 - 580. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Liang and J. L. Pietrusz Thiol-Related Genes in Diabetic Complications: A Novel Protective Role for Endogenous Thioredoxin 2 Arterioscler Thromb Vasc Biol, January 1, 2007; 27(1): 77 - 83. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-P. Yip Flash photolysis of caged nitric oxide inhibits proximal tubular fluid reabsorption in free-flow nephron Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2005; 289(2): R620 - R626. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Okamoto, K. Tsuchiya, Y. Kanematsu, Y. Izawa, M. Yoshizumi, S. Kagawa, and T. Tamaki Nitrite-derived nitric oxide formation following ischemia-reperfusion injury in kidney Am J Physiol Renal Physiol, January 1, 2005; 288(1): F182 - F187. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nakamura, J. Hirano, and M. Kubokawa Regulation of an inwardly rectifying K+ channel by nitric oxide in cultured human proximal tubule cells Am J Physiol Renal Physiol, September 1, 2004; 287(3): F411 - F417. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-H. Jin, H. E. McGrath, J. J. Gildea, H. M. Siragy, R. A. Felder, and R. M. Carey Renal Interstitial Guanosine Cyclic 3', 5'-Monophosphate Mediates Pressure-Natriuresis Via Protein Kinase G Hypertension, May 1, 2004; 43(5): 1133 - 1139. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sasaki, H. M. Siragy, J. J. Gildea, R. A. Felder, and R. M. Carey Production and Role of Extracellular Guanosine Cyclic 3', 5' Monophosphate in Sodium Uptake in Human Proximal Tubule Cells Hypertension, February 1, 2004; 43(2): 286 - 291. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Mark, A. R. Burroughs, R. C. Brown, J. D. Huber, and T. P. Davis Nitric oxide mediates hypoxia-induced changes in paracellular permeability of cerebral microvasculature Am J Physiol Heart Circ Physiol, January 1, 2004; 286(1): H174 - H180. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Gunduz, O. Kuru, and U. K. Senturk Effect of nitric oxide on exercise-induced proteinuria in rats J Appl Physiol, November 1, 2003; 95(5): 1867 - 1872. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Turban, X.-Y. Wang, and M. A. Knepper Regulation of NHE3, NKCC2, and NCC abundance in kidney during aldosterone escape phenomenon: role of NO Am J Physiol Renal Physiol, November 1, 2003; 285(5): F843 - F851. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Cowley Jr., T. Mori, D. Mattson, and A.-P. Zou Role of renal NO production in the regulation of medullary blood flow Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2003; 284(6): R1355 - R1369. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Vetter, Z.-J. Chen, G.-D. Chang, D. Che, S. Liu, and C.-H. Chang Cyclosporin A Disrupts Bradykinin Signaling Through Superoxide Hypertension, May 1, 2003; 41(5): 1136 - 1142. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Handa, J. W. Strandhoy, C. E. Giammattei, and S. E. Handa Platelet-activating factor and solute transport processes in the kidney Am J Physiol Renal Physiol, February 1, 2003; 284(2): F274 - F281. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B. Persson Nitric oxide in the kidney Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2002; 283(5): R1005 - R1007. [Full Text] [PDF] |
||||
![]() |
A. K. Gupta and B. C. Kone USF-1 and USF-2 trans-repress IL-1beta -induced iNOS transcription in mesangial cells Am J Physiol Cell Physiol, October 1, 2002; 283(4): C1065 - C1072. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Wang Role of iNOS and eNOS in modulating proximal tubule transport and acid-base balance Am J Physiol Renal Physiol, October 1, 2002; 283(4): F658 - F662. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Gill, S. Saksena, I. A. Syed, S. Tyagi, W. A. Alrefai, J. Malakooti, K. Ramaswamy, and P. K. Dudeja Regulation of NHE3 by nitric oxide in Caco-2 cells Am J Physiol Gastrointest Liver Physiol, September 1, 2002; 283(3): G747 - G756. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-W. Yang, M.-S. Wu, M.-J. Pan, W.-J. Hsieh, A. Vandewalle, and C.-C. Huang The Leptospira Outer Membrane Protein LipL32 Induces Tubulointerstitial Nephritis-Mediated Gene Expression in Mouse Proximal Tubule Cells J. Am. Soc. Nephrol., August 1, 2002; 13(8): 2037 - 2045. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Baines and P. Ho Glucose stimulates O2 consumption, NOS, and Na/H exchange in diabetic rat proximal tubules Am J Physiol Renal Physiol, August 1, 2002; 283(2): F286 - F293. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Scholz Adaptational responses to hypoxia Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2002; 282(6): R1541 - R1543. [Full Text] [PDF] |
||||
![]() |
P. A. Ortiz and J. L. Garvin Role of nitric oxide in the regulation of nephron transport Am J Physiol Renal Physiol, May 1, 2002; 282(5): F777 - F784. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Notenboom, D. S. Miller, P. Smits, F. G. M. Russel, and R. Masereeuw Role of NO in endothelin-regulated drug transport in the renal proximal tubule Am J Physiol Renal Physiol, March 1, 2002; 282(3): F458 - F464. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Ortiz, N. J. Hong, and J. L. Garvin NO decreases thick ascending limb chloride absorption by reducing Na+-K+-2Cl- cotransporter activity Am J Physiol Renal Physiol, November 1, 2001; 281(5): F819 - F825. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Liang, T. J. Berndt, and F. G. Knox Mechanism underlying diuretic effect of L-NAME at a subpressor dose Am J Physiol Renal Physiol, September 1, 2001; 281(3): F414 - F419. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |